Old Web
English
Sign In
Acemap
>
authorDetail
>
Ivona Filic
Ivona Filic
Brigham and Women's Hospital
squamous carcinoma
Bromodomain
BRD4
BET inhibitor
Biology
3
Papers
20
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Chemical Screen Identifies Diverse and Novel Histone Deacetylase Inhibitors as Repressors of NUT Function: Implications for NUT Carcinoma Pathogenesis and Treatment.
2021
Molecular Cancer Research
Hitoshi Shiota
Artyom A. Alekseyenko
Zhipeng A. Wang
Ivona Filic
Tatiana M. Knox
Nhi M. Luong
Yeying Huang
David A. Scott
Kristen Jones
Prafulla C. Gokhale
Madeleine E. Lemieux
Philip A. Cole
Mitzi I. Kuroda
Christopher A. French
Show All
Source
Cite
Save
Citations (0)
Combined targeting of the BRD4-NUT-p300 axis in NUT midline carcinoma by dual selective bromodomain inhibitor, NEO2734.
2020
Molecular Cancer Therapeutics
Chevaun D Morrison-Smith
Tatiana Knox
Ivona Filic
Kara M Soroko
Benjamin K. Eschle
Margaret K. Wilkens
Prafulla C. Gokhale
Francis J. Giles
Andrew Griffin
bill brown
Geoffrey I. Shapiro
Beth E. Zucconi
Philip A. Cole
Madeleine E. Lemieux
Christopher A. French
Show All
Source
Cite
Save
Citations (20)
Abstract B014: Novel dual BET/p300 bromodomain inhibitors therapeutically inhibit BRD4-NUT driven NUT Carcinomas
2019
Molecular Cancer Therapeutics
Chevaun D Morrison-Smith
Amy DiBona
Erica M. Walsh
Kristina Danga
Ivona Filic
Tatiana Knox
Adlai R. Grayson
Michael J. Cameron
Christopher A. French
Show All
Source
Cite
Save
Citations (0)
1